Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome InteractionsBIOCONJUGATE CHEMISTRYIF3.92024-07-112OAAI
Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint eraESMO OPENIF8.32024-02-012OAAI
Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint eraCANCER RESEARCHIF16.62023-04-040PRE
Survival impact and trends of immunotherapy use in metastatic merkel cell carcinoma in the checkpoint era: analysis of a large databaseCANCER RESEARCHIF16.62023-04-040PRE
Precision oncology and tumor mutational burden (TMB) in Merkel cell carcinoma (MCC): An analysis of the AACR Project Genie real-world databaseANNALS OF ONCOLOGYIF65.42022-09-010OA
The cure from within? a review of the microbiome and diet in melanomaCANCER AND METASTASIS REVIEWSIF8.72022-04-279OAAI
Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative studyBMC PUBLIC HEALTHIF3.62021-05-2825OAAI
Needs of Individuals Living With Hepatitis Delta Virus and Their Caregivers, 2016-2019PREVENTING CHRONIC DISEASEIF3.92020-12-175OAAI
Effect of Ustekinumab Dose Escalation on Recapturing Clinical Response in Patients With Crohn's DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62019-10-012OAAI
The Socioeconomic Impact on Presentation and Clinical Course of Celiac DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62019-10-010OA
IMPLEMENTATION OF GOLD STANDARDS FRAMEWORK IN AN ACUTE HOSPITAL SETTING, A QUALITY IMPROVEMENT PROJECTAGE AND AGEINGIF7.12018-09-040OAAI